Sign in to your account
or
By signing in you agree to our
Terms & conditions
 and 
Privacy policy
Sku Image
Sku Image
Sku Image
Sku Image

Elduxio 76mg Solution for Injection

Elranatamab (40mg/ml)
Genuine
Authenticity Assured
Prescription
required
Cold stored
Stored between 2-8°C
Elduxio 76mg Solution for Injection is used to treat relapsed and refractory multiple myeloma (blood cancer). This medicine helps the body’s immune system to identify and attack multiple myeloma cells, specifically in those who are unresponsive to earlier treatment.

Written By Dr. Sakshi Jain, MS, BDS,
Reviewed By Dr. Rajeev Sharma, MBA, MBBS,
Last updated on 24 Jun 2026 | 11:35 AM (IST)
₹207217
₹257733
20% off
Get for
₹206217
right chevron icon
on orders above ₹1200
Use Code 1MGNEWPLUS
Get for
₹206217
right chevron icon
on orders above ₹300
Use Code 1MGNEW
1/2
Welcome Gift | For First Order
15% EXTRA OFF
1.9 ml Solution for Injection
Get by Today
Delivery Icon
Location Icon
Gurgaon
Payment

Payment

Online only

Return

Return

Not available

 Expiry after

Expiry after

Sep, 2026

 
 
0
footer-icon

Save more with additional offers

offer icon
Flat ₹30 cashback. T&C Apply*
Flat ₹30 cashback. T&C Apply*
chevron icon
offer icon
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
chevron icon
offer icon
Earn cashback up to Rs.75 with Amazon Pay Later
Earn cashback up to Rs.75 with Amazon Pay Later
chevron icon
offer icon
Flat ₹30 cashback. T&C Apply*
Flat ₹30 cashback. T&C Apply*
chevron icon
offer icon
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
chevron icon
offer icon
Earn cashback up to Rs.75 with Amazon Pay Later
Earn cashback up to Rs.75 with Amazon Pay Later
chevron icon
offer icon
Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15
Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15
chevron icon
offer icon
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI.
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI.
chevron icon

General Information

Contains

Elranatamab (40mg/ml)

Marketer

Pfizer Ltd

Storage

Store in a refrigerator (2 - 8°C). Do not freeze.
The content is shown in English
Elduxio 76mg Solution for Injection image
Elduxio 76mg Solution for Injection image
Elduxio 76mg Solution for Injection image
Elduxio 76mg Solution for Injection image

Product introduction

Attend all the scheduled treatment visits and take Elduxio 76mg Solution for Injection exactly as prescribed. Regular monitoring is important to identify serious reactions such as cytokine release syndrome (CRS) or neurologic toxicity early during therapy.


Common side effects of Elduxio 76mg Solution for Injection include cytokine release syndrome, fatigue, injection-site reactions, and a decrease in hemoglobin, white blood cells, and platelets. If any discomfort becomes bothersome or does not improve, it is best to inform your doctor for guidance.


Patients should be monitored closely during treatment because Elduxio 76mg Solution for Injection may cause neurologic toxicity, including immune effector cell-associated neurotoxicity syndrome (ICANS), as well as serious and life-threatening reactions. If you have any active infection, caution is advised when taking Elduxio 76mg Solution for Injection. Women should use effective contraception during treatment and for 4 months after the last dose of this medicine.

Uses of Elduxio Solution for Injection

  • Multiple myeloma : A condition that is a type of blood cancer that affects plasma cells, which are located in the bone marrow. It can cause bone damage, anemia, infections, kidney problems, and weakness.

Benefits of Elduxio Solution for Injection

Multiple myeloma
Multiple myeloma is a type of blood cancer in which cancer cells continue to grow and affect immune function and the production of normal blood cells. Elduxio 76mg Solution for Injection helps the immune system to attack multiple myeloma cells and reduce the spread of cancerous cells in the body. It may help improve disease control in patients whose cancer has returned or is not responding to earlier treatments.

Side effects of Elduxio Solution for Injection

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Elduxio
  • Cytokine release syndrome
  • Fatigue
  • Injection site reactions (pain, swelling, redness)
  • Diarrhea
  • Upper respiratory tract infection
  • Musculoskeletal (bone, muscle or joint) pain
  • Pneumonia
  • Decreased appetite
  • Rash
  • Cough
  • Nausea
  • Fever
  • Decreased white blood cell count (lymphocytes)
  • Decreased white blood cell count (neutrophils)
  • Decreased hemoglobin
  • Decreased blood cells (red cells, white cells, and platelets)

How to use Elduxio Solution for Injection

Your doctor or nurse will guide you how to use this medicine.

How Elduxio Solution for Injection works

Elduxio 76mg Solution for Injection is an antibody medicine that attaches to multiple myeloma cells carrying a marker called BCMA (B-cell maturation antigen). It helps the body’s immune system recognize and attack these cancer cells by bringing immune cells closer to them. This helps kill myeloma cells and slows the growth of the cancer.

All substitutes for Elduxio 76mg Solution for Injection

For information purposes only. Consult a doctor before taking any medicine.

Quick tips

  • Inform your doctor immediately if you develop fever, chills, confusion, breathing difficulty, severe weakness, or changes in alertness after treatment.
  • Maintain infection precautions, such as proper hand hygiene and avoiding close contact with people who have active infections, as treatment may weaken immune defenses.
  • Stay well-hydrated and maintain balanced nutrition during treatment to help support recovery and overall health.
  • Do not drive, operate heavy machinery, or perform activities requiring full alertness if you experience dizziness, confusion, or neurologic symptoms after receiving Elduxio 76mg Solution for Injection.
  • Patients should inform their doctor about all medicines they are taking, including prescription medicines, supplements, and herbal products, to help avoid treatment-related complications.

Safety advice

Alcohol

Alcohol

CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Elduxio 76mg Solution for Injection. Please consult your doctor.
Pregnancy

Pregnancy

CONSULT YOUR DOCTOR
Information regarding the use of Elduxio 76mg Solution for Injection during pregnancy is not available. Please consult your doctor.
Breast feeding

Breast feeding

CONSULT YOUR DOCTOR
Elduxio 76mg Solution for Injection may be unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. It should be used only if the expected benefit outweighs the potential risk. Please consult your doctor.
Driving

Driving

UNSAFE
Elduxio 76mg Solution for Injection may cause side effects that could affect your ability to drive.
Kidney

Kidney

CAUTION
Elduxio 76mg Solution for Injection should be used with caution in patients with kidney disease. Dose adjustment may be needed.
Liver

Liver

CAUTION
Elduxio 76mg Solution for Injection should be used with caution in patients with liver disease. Dose adjustment may be needed.

Frequently asked questions

Step-up dosing refers to receiving lower initial doses before moving to full treatment doses under close medical supervision. It is used to reduce the risk of cytokine release syndrome (CRS). It is a serious immune reaction that can occur during treatment.
CRS is an immune-related reaction that may occur when the immune system becomes highly activated during treatment. Symptoms may include fever, chills, low blood pressure, breathing difficulty, headache, or rapid heartbeat. Early monitoring is important because CRS can become serious in some patients.
Yes, it may cause neurologic toxicity, including confusion, dizziness, headache, difficulty speaking, sleepiness, or changes in alertness. Patients are monitored carefully for these symptoms during treatment.
The first few doses carry a higher risk of CRS and neurologic side effects. Because of these factors, hospitalization and close observation may be required after initial step-up doses to ensure patient safety.
Yes, it can weaken immune defenses and increase the risk of serious infections, including pneumonia and sepsis. Patients should immediately report symptoms such as fever, cough, sore throat, or breathing difficulty.
Yes. Regular monitoring of blood counts, liver function, and signs of infection is important during treatment to help identify side effects early and guide treatment decisions.

Fact Box

Chemical Class

Monoclonal antibody

Habit Forming

No

Therapeutic Class

ANTI NEOPLASTICS

Action Class

Monoclonal Antibodies (mAbs)
100% genuine products
100% genuine products
Safe & secure payments
Safe & secure payments
No contact delivery
No contact delivery
Fully sanitized facilities
Fully sanitized facilities
<h3 class=titleMediumExtraBold>Want to know more</h3>

Want to know more

We provide you with authentic, trustworthy and relevant information
<h3 class=titleMediumExtraBold>Have issue with the content</h3>

Have issue with the content

Disclaimer

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Marketer details

Name: Pfizer Ltd
Address: The Capital, 1802, 18th Floor , Plot No. C-70, ‘G’ Block , Bandra Kurla Complex, Bandra East , Mumbai – 400051.

Importer details

Name: Pfizer Products India Private Limited
Address: The Capital – B Wing, 1802, 18th Floor, Plot No. C-70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051, India.

Vendor Details

Country of origin: United states
A licensed vendor partner from your nearest location will deliver Elduxio 76mg Solution for Injection. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.

In case of any issues, contact us

Email ID: [email protected]
Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India
Why we need a prescription?
Cold chain description image
close sheet